Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsistently described. An objective of the European Stroke Organisation (ESO) Health Economics Working Group is to standardise and improve the economic evaluations of interventions for stroke. Methods: The ESO Health Economics Working Group and additional experts were contacted to develop a protocol and a guidance document for data collection for economic evaluations of stroke therapies. A modified Delphi approach, including a survey and consensus processes, was used to agree on content. We also asked the participants about resources that could be shared to improve economic evaluations of interventions for stroke. Results: Of 28 experts invited, ...
Background and Purpose— Cost-effectiveness data for stroke interventions are limited, and comp...
Background and Purpose - Value-based health care aims to bring together patients and health systems ...
Background and purpose: Cost-of-illness studies often describe a single aggregate cost of a disease...
Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsistently ...
Abstract Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsi...
Introduction Approaches to economic evaluations of stroke therapies are varied and inconsistently d...
Introduction Approaches to economic evaluations of stroke therapies are varied and inconsistently de...
Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsistently d...
IntroductionApproaches to economic evaluations of stroke therapies are varied and inconsistently des...
Background: Stroke is one of the most significant social and health issues at the global level. In i...
Many stroke rehabilitation services and interventions are complex in that they involve a number of c...
Many stroke rehabilitation services and interventions are complex in that they involve a number of c...
Rationale: A key objective of A Very Early Rehabilitation Trial is to determine if the intervention,...
Rationale: A key objective of A Very Early Rehabilitation Trial is to determine if the intervention,...
Background and purpose: Cost-of-illness studies often describe a single aggregate cost of a disease ...
Background and Purpose— Cost-effectiveness data for stroke interventions are limited, and comp...
Background and Purpose - Value-based health care aims to bring together patients and health systems ...
Background and purpose: Cost-of-illness studies often describe a single aggregate cost of a disease...
Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsistently ...
Abstract Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsi...
Introduction Approaches to economic evaluations of stroke therapies are varied and inconsistently d...
Introduction Approaches to economic evaluations of stroke therapies are varied and inconsistently de...
Introduction: Approaches to economic evaluations of stroke therapies are varied and inconsistently d...
IntroductionApproaches to economic evaluations of stroke therapies are varied and inconsistently des...
Background: Stroke is one of the most significant social and health issues at the global level. In i...
Many stroke rehabilitation services and interventions are complex in that they involve a number of c...
Many stroke rehabilitation services and interventions are complex in that they involve a number of c...
Rationale: A key objective of A Very Early Rehabilitation Trial is to determine if the intervention,...
Rationale: A key objective of A Very Early Rehabilitation Trial is to determine if the intervention,...
Background and purpose: Cost-of-illness studies often describe a single aggregate cost of a disease ...
Background and Purpose— Cost-effectiveness data for stroke interventions are limited, and comp...
Background and Purpose - Value-based health care aims to bring together patients and health systems ...
Background and purpose: Cost-of-illness studies often describe a single aggregate cost of a disease...